| 000 | 00000nam 22000008i 4500 |
| 001 | 9.914268 |
| 003 | CaOODSP |
| 005 | 20221221135918 |
| 006 | m o d f |
| 007 | cr ||||||||||| |
| 008 | 220809t20222022onc o f000 0 eng d |
| 020 | |a9780660449555 |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aH164-342/2022E-PDF |
| 245 | 00|aGuidance document : |bpost-notice of compliance changes - guidance for safety and efficacy of veterinary drugs. |
| 246 | 17|aPost-NOC changes for safety and efficacy for veterinary drugs |
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada,|c2022. |
| 264 | 4|c©2022 |
| 300 | |a1 online resource (17 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aIssued also in French under title: Ligne directrice : changements survenus après l’avis de conformité : lignes directrices sur l’innocuité et l’efficacité des médicaments vétérinaires. |
| 500 | |a"July 28, 2022." |
| 500 | |a"Pub.: 220365." |
| 650 | 0|aDrugs|xLabeling|zCanada. |
| 650 | 0|aDrug approval|zCanada. |
| 650 | 0|aVeterinary drugs|zCanada. |
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
| 775 | 08|tLigne directrice : |w(CaOODSP)9.914269 |
| 856 | 40|qPDF|s1.28 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H164-342-2022-eng.pdf |